The gut microbiota influences blood-brain barrier permeability in mice

合集下载

去甲泽拉木醛通过抑制AKT

去甲泽拉木醛通过抑制AKT

关系仍需要进一步探究。

综上所述,TLR4介导的炎症反应在帕金森病发病机制中的作用被广泛关注,本研究证实,MPTP 诱导的帕金森病小鼠模型同样存在TLR4活化的现象,并可能通过“肠-脑”轴双向作用加剧炎症级联反应。

而白藜芦醇可能通过抑制LPS 诱导的TLR4/MyD88/NF-κB 信号通路的激活缓解炎症反应,修复肠道屏障,并减少α-syn 在肠道的累积,进而发挥保护多巴胺能神经元的效应。

参考文献:[1]Pajares M,I Rojo A,Manda G,et al.Inflammation in Parkinson'sdisease:mechanisms and therapeutic implications [J ].Cells,2020,9(7):1687-93.[2]Wang R,Shih LC.Parkinson's disease-current treatment [J ].CurrOpin Neurol,2023,36(4):302-8.[3]Bashir Y ,Khan AU.The interplay between the gut-brain axis and themicrobiome:a perspective on psychiatric and neurodegenerative dis-orders [J ].Front Neurosci,2022,16:1030694-9.[4]Su M,Tang T,Tang WW,et al.Astragalus improves intestinal barrierfunction and immunity by acting on intestinal microbiota to treat T2DM:a research review [J ].Front Immunol,2023,14:1243834-42.[5]Wasiak J,Gawlik-Kotelnicka O.Intestinal permeability and itssignificance in psychiatric disorders-A narrative review and future perspectives [J ].Behav Brain Res,2023,448:114459-63.[6]Su Y ,Shi CH,Wang T,et al.Dysregulation of peripheral monocytesand pro-inflammation of alpha-synuclein in Parkinson's disease [J ].J Neurol,2022,269(12):6386-94.[7]Li JP,Liu X,Wu YZ,et al.Aerobic exercise improves intestinalmucosalbarrierdysfunctionthroughTLR4/MyD88/NF-κBsignaling pathway in diabetic rats [J ].Biochem Biophys Res Commun,2022,634:75-82.[8]郭野,陈美霓,李家萱.白藜芦醇的临床应用研究进展[J ].新乡医学院学报,2023,40(3):290-4.[9]Jiang H,Ni J,Hu LS,et al.Resveratrol may reduce the degree ofperiodontitis by regulating ERK pathway in gingival-derived MSCs [J ].Int J Mol Sci,2023,24(14):11294-9.[10]Mannino D,Scuderi SA,Casili G,et al.Neuroprotective effects ofGSK-343in an in vivo model of MPTP-induced nigrostriatal degeneration [J ].J Neuroinflammation,2023,20(1):155-63.[11]Li JY ,Zhao JW,Chen LM,et al.α-Synuclein induces Th17differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson's disease [J ].Brain Behav Immun,2023,108:32-44.[12]安云英.白藜芦醇改善帕金森病小鼠相关症状及其对肠道菌群的影响[D ].新乡:新乡医学院,.[13]李琪,陈碾,罗金定,等.二氢杨梅素经激活AMPK/ULK1通路改善2型糖尿病大鼠帕金森病样病变[J ].生理学报,2023,9(1):59-68.[14]Yan YQ,Zheng R,Liu Y ,et al.Parkin regulates microglial NLRP3and represses neurodegeneration in Parkinson's disease [J ].Aging Cell,2023,22(6):e13834-40.[15]Su CF,Jiang L,Zhang XW,et al.Resveratrol in rodent models ofParkinsons disease:a systematic review of experimental studies [J ].图6RES 下调脑黑质区TLR4的表达,上调TH 的表达Fig.6RES downregulates the expression of TLR4and upregulates the expression of TH in the substantia nigra of the mice.A:Immunofluorescence double-stained image of TLR4-positive neurons (red fluorescence)and TH-positive neurons (green fluorescence)in the substantia nigra of the mice.The fluorescence intensity represents the level of expression (Scale bar:100μm).B:Expression of TLR4.C:Expression of TH.*P <0.05,**P <0.01.M P T P +R E S 30M P T PC o n t r o lT L R 4e x p r e s s i o n500450400350300250200150100500ControlMPTP MPTP+RES30Control MPTP MPTP+RES30T H e x p r e s s i o n40003500300025002000150010005000ABC MERGETLR4TH*****J South Med Univ,2024,44(2):270-279··278Front Pharmacol,2021,12:644219-25.[16]Shahcheraghi SH,Salemi F,Small S,et al.Resveratrol regulates inflammation and improves oxidative stress via Nrf2signaling pathway:therapeutic and biotechnological prospects[J].Phytother Res,2023,37(4):1590-605.[17]Gao YN,Meng QW,Qin JW,et al.Resveratrol alleviates oxidative stress induced by oxidized soybean oil and improves gut function via changing gut microbiota in weaned piglets[J].J Anim Sci Biotechnol,2023,14(1):54-63.[18]Shaito A,Al-Mansoob M,Ahmad SMS,et al.Resveratrol-mediated regulation of mitochondria biogenesis-associated pathways in neurodegenerative diseases:molecular insights and potential therapeutic applications[J].Curr Neuropharmacol,2023,21(5): 1184-201.[19]Zhang L,Kang QZ,Kang MX,et al.Regulation of main ncRNAs by polyphenols:a novel anticancer therapeutic approach[J].Phytomedicine,2023,120:155072-83.[20]Tao J,An YY,Xu LY,et al.The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol [J].Food Funct,2023,14(10):4647-61.[21]Yang LC,Wang YB,Li ZW,et al.Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease[J].Carbohydr Polym,2023,310:120714-21.[22]Cannon T,Gruenheid S.Microbes and Parkinson's disease:from associations to mechanisms[J].Trends Microbiol,2022,30(8):749-60.[23]Goya ME,Xue F,Sampedro-Torres-Quevedo C,et al.Probiotic Bacillus subtilis protects againstα-synuclein aggregation in C.elegans[J].Cell Rep,2020,30(2):367-80.e7.[24]Ramezani M,Wagenknecht-Wiesner A,Wang T,et al.Alpha synuclein modulates mitochondrial Ca2+uptake from ER during cell stimulation and under stress conditions[J].bioRxiv,2023: 2023.04.23.537965.[25]Duan YN,Wang YX,Liu YH,et al.Circular RNAs in Parkinson's disease:reliable biological markers and targets for rehabilitation[J].Mol Neurobiol,2023,60(6):3261-76.[26]Aho VTE,Houser MC,Pereira PAB,et al.Relationships of gut microbiota,short-chain fatty acids,inflammation,and the gut barrier in Parkinson's disease[J].Mol Neurodegener,2021,16(1):6-12.[27]Kumari S,Taliyan R,Dubey prehensive review on potential signaling pathways involving the transfer ofα-synuclein from the gut to the brain that leads to Parkinson's disease[J].ACS Chem Neurosci,2023,14(4):590-602.[28]Roe K.An alternative explanation for Alzheimer's disease and Par-kinson's disease initiation from specific antibiotics,gut microbiotadysbiosis and neurotoxins[J].Neurochem Res,2022,47(3):517-30.[29]Kleine Bardenhorst S,Cereda E,Severgnini M,et al.Gut microbiota dysbiosis in Parkinson disease:a systematic review and pooledanalysis[J].Eur J Neurol,2023,30(11):3581-94.[30]Zhao Z,Ning JW,Bao XQ,et al.Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressinginflammation mediated by the lipopolysaccharide-TLR4signalingpathway through the microbiota-gut-brain axis[J].Microbiome,2021,9(1):226-35.[31]Wang WX,Bale S,Yalavarthi B,et al.Deficiency of inhibitory TLR4 homolog RP105exacerbates fibrosis[J].JCI Insight,2022,7(21):e160684-90.[32]De Ciucis CG,Fruscione F,De Paolis L,et al.Toll-like receptors and cytokine modulation by goat milk extracellular vesicles in a modelof intestinal inflammation[J].Int J Mol Sci,2023,24(13):11096-105.[33]Wang QH,Botchway BOA,Zhang Y,et al.Ellagic acid activates the Keap1-Nrf2-ARE signaling pathway in improving Parkinson'sdisease:a review[J].Biomed Pharmacother,2022,156:113848-55.[34]da Costa RO,Gadelha-Filho CVJ,de Aquino PEA,et al.Vitamin D (VD3)intensifies the effects of exercise and prevents alterations ofbehavior,brain oxidative stress,and neuroinflammation,inhemiparkinsonian rats[J].Neurochem Res,2023,48(1):142-60.[35]Sarkar S.Microglial ion channels:key players in non-cell autono-mous neurodegeneration[J].Neurobiol Dis,2022,174:105861-8.[36]Chen MT,Hou PF,Zhou M,et al.Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrierintegrity and inhibiting gut inflammation through regulation of theendocannabinoid system[J].Clin Nutr,2020,39(4):1264-75.[37]Lei JR,Tu XK,Wang Y,et al.Resveratrol downregulates the TLR4 signaling pathway to reduce brain damage in a rat model of focalcerebral ischemia[J].Exp Ther Med,2019,17(4):3215-21.[38]Wang P,Chen Q,Tang ZQ,et al.Uncovering ferroptosis in Parkinson's disease via bioinformatics and machine learning,andreversed deducing potential therapeutic natural products[J].FrontGenet,2023,14:1231707-18.[39]黄庆洋,纪东东,田绣云,等.小檗碱通过激活Nrf2-HO-1/GPX4通路抑制小鼠海马神经元HT22细胞的铁死亡[J].南方医科大学学报,2022,42(6):937-43.[40]Mirzaei H,Sedighi S,Kouchaki E,et al.Probiotics and the treatment of Parkinson's disease:an update[J].Cell Mol Neurobiol,2022,42(8):2449-57.(编辑:林萍) J South Med Univ,2024,44(2):270-279··279肺癌是全球最常诊断的癌症之一,也是癌症相关死亡的主要原因,其中非小细胞肺癌(NSCLC )是肺癌最常见的一种亚型,占比达80%[1,2]。

多发性硬化--英文

多发性硬化--英文

Incidence has since decreased This disease course is steadily progressing. Can present with or without clear-cut relapses.
Diagnosing MS
A diagnosis by exclusion eliminate other disease states that may explain symptoms before suggesting MS Patients undergo clinical, laboratory (hematology and CSF panels), and imaging studies to confirm diagnosis
http://multiplesclerosis. net/what-isms/statistics/
Symptoms of MS
Muscle weakness Visual symptoms
Blurry vision • Double vision

Unsteady gait/balance issues Pain/Paresthesias Emotional/Cognitive disturbances
MRI MRI findings that strongly suggestive of MS • 4 or more white matter lesions (each > 3mm) •3 white matter lesions, 1 periventricular Lesions 6 mm diameter or greater •Ovoid lesions, oriented perpendicular to ventricles •Corpus callosum lesions Brainstem lesions •Open ring appearance of gadolinium enhancement

肝功能不全

肝功能不全

(2) False neurotransmitters and liver coma
N:苯丙氨酸↑ 肠菌 苯乙胺 (Intest.) (blood) 酪氨酸↑ (decarboxylase) 酪胺 (portal vein) liver ( monoamine oxidase) clearance Liver: 苯乙胺↑、 酪胺↑ → brain failure β-hydroxylase 苯乙醇胺 羟苯乙醇胺 replace NE、DA,but its physiological effect is weak coma
NH3
K+
Na+-K+-ATPase
Na+
Summary of ammonia intoxication
Severe hepatic dysfunction Urea synthesis
production of ammonia↑
hyperammonemia Brain dysfunction Elevated level of brain ammonia
(1) Ammonia interferes with brain energy metabolism: ATP production ↓, expending↑
α酮戊二酸↓
谷氨酸 ATP ↓ NH3+NADH ↓+H+ H2O+NAD+
Glutamic acid+NH3
(丙酮酸脱羧酶)
glutamine
Hormone regulation of AA imbalance and NT production
Hepatic dysfunction Portal systemic circulation Dysfunction in excitation

Gut Microbiota and Liver Diseases

Gut Microbiota and Liver Diseases

Gut Microbiota and Liver Diseases The relationship between gut microbiota and liver diseases is a complex and fascinating area of study that has garnered increasing attention in recent years. The human gut is home to trillions of microorganisms, including bacteria, viruses, and fungi, collectively known as the gut microbiota. These microorganisms play a crucial role in maintaining the overall health of the host, including the healthof the liver. The liver is a vital organ responsible for numerous metabolic functions, and its health is closely linked to the composition and function of the gut microbiota. One perspective to consider is the impact of gut dysbiosis, or an imbalance in the gut microbiota, on the development of liver diseases. Researchhas shown that alterations in the gut microbiota composition and function can contribute to the pathogenesis of various liver conditions, such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), and liver cirrhosis. For example, an overgrowth of harmful bacteria or a decrease in beneficialbacteria in the gut can lead to increased intestinal permeability, allowingharmful substances to enter the liver and trigger inflammation and damage. Furthermore, the gut microbiota plays a crucial role in the metabolism of dietary components and drugs, which can have direct implications for liver health. For instance, certain gut bacteria are involved in the metabolism of bile acids, which are essential for the digestion and absorption of fats. Disruptions in thisprocess due to gut dysbiosis can lead to the accumulation of toxic bile acids in the liver, contributing to liver injury. Additionally, the gut microbiota can influence the metabolism of alcohol and drugs, affecting their impact on the liver. These insights highlight the intricate ways in which the gut microbiota can influence liver function and disease development. Another perspective to consider is the potential for modulating the gut microbiota as a therapeutic approach for liver diseases. The concept of using probiotics, prebiotics, and synbiotics to restore a healthy gut microbiota and improve liver health has gained traction in both research and clinical settings. Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits on the host. Prebiotics are non-digestible fibers that promote the growth of beneficial gut bacteria. Synbiotics refer to a combination of probiotics and prebiotics that worksynergistically to improve gut microbiota composition and function. Several studies have demonstrated the potential of probiotics in mitigating liver diseases by modulating gut microbiota composition, enhancing gut barrier function, reducing inflammation, and improving metabolic processes. For example, certain strains of probiotics have been shown to reduce hepatic fat accumulation in NAFLD and alleviate liver injury in ALD. Similarly, prebiotics have been found to exert beneficial effects on liver health by promoting the growth of beneficial bacteria and enhancing gut barrier function. These findings underscore the therapeutic potential of targeting the gut microbiota to manage liver diseases. It is also important to acknowledge the challenges and limitations associated with modulating the gut microbiota for liver disease management. The diversity and individuality of the gut microbiota make it challenging to identify universally effective probiotics or prebiotics for liver diseases. Additionally, the survival and functionality of probiotics in the gut environment, as well as their potential interactions with existing gut microbiota, are important considerations. Moreover, the optimal dosing, duration, and combination of probiotics and prebiotics for different liver conditions require further investigation. These complexities highlight the need for personalized approaches and continued research in this field. In conclusion, the relationship between gut microbiota and liver diseases is a multifaceted and dynamic area of research with significant implications for human health. The gut microbiota exerts profound effects on liver function and disease development through various mechanisms, including the modulation of gut barrier function, metabolism of dietary components and drugs, and immune regulation. Understanding these intricate interactions provides valuable insights into the pathogenesis of liver diseases and offers potential avenues for therapeutic interventions. While the modulation of the gut microbiota shows promise as a strategy for managing liver diseases, further research is needed to overcome the challenges and optimize the therapeutic potential of this approach. Overall, the evolving understanding of gut-liver axis highlights the interconnectedness of different organ systems and the importance of considering the gut microbiota in the context of liver health.。

FERMENTED FOODS FOR GUT HEALTH

FERMENTED FOODS FOR GUT HEALTH

FERMENTED FOODS FOR GUT HEALTHFermented foods are highly beneficial to your health. However, the underlying practices regarding human consumption (the Paleolithic tradition of eating them) and the new scientific developments regarding just how these foods are bioactive – are two vastly underrepresented areas of knowledge. I hope to cover both areas and explain just why our ancestors instinctually sought out fermented foods, and what we now know about the exact scientific mechanisms that underlie their function in the human body, as well as the brain.Firstly, our Paleolithic ancestors consumed honey, fruits or berries, and their juices, which were unknowingly subjected to natural microbial fermentation.1It didn‟t take salient scientific literature to suggest these fermented foods were optimal for their health.2 Fermented foods have mentally stimulating properties, analgesic properties, sedating properties, and many other positive functions.3 Interestingly, the shift away from traditional diets has been marked with not only changes in gut microflora, but also an increase in depression and negative mental health conditions.4Agrawal, Rahul, and Fernando Gomez-Pinilla. “…Metabolic Syndrome‟ in the Brain: Deficiency in Omega-3 Fatty Acid Exacerbates Dysfunctions in Insulin Receptor Signalling and Cognition.” The Journal of Physiology 590.Pt 10 (2012): 2485–2499. PMC.Kodl, Christopher T., and Elizabeth R. Seaquist. “Cognitive Dysfunction and Diabetes Mellitus.” Endocrine Reviews 29.4 (2008):494–511. PMC. Web. 19 Dec. 2014.Historically, traditional diets are correlated with lower levels of anxiety and depression. Plainly stated in one study‟s conclusion, “those with better quality diets were less likely to be depressed, whereas a higher intake of processed and unhealthy foods was associated with increasedanx iety.”15 What do almost all traditional diets have in common? They contain fermented foods. In fact, fermented foods and beverages can comprise anywhere between 5-40% of the human diet in some populations.16 In addition, important groups of gut bacteria, often considered markers of a healthy gut, are inversely associated with obesity.17,18,19“The Role and Influence of Gut Microbiota in Pathogenesis and Management of Obesity and Metabolic …” Frontiers. N.p., n.d. We b.19 Dec. 2014.Furthermore, in mice, the absence of toll-like receptor 5 alters the gut microbiota – leading to more food intake, insulin resistance, and obesity.20 Eating fermented foods helps to favorably effect the composition of the gut microbiota.21 In addition, epidemiological studies have shown thatconsumption of cabbage and sauerkraut is connected with a significant reduction of breast cancer occurrences.22So, how did our Paleolithic ancestors know that fermented foods would be beneficial? This answer remains unclear, even though traditions were passed down from generation to generation. Fermentation of food increases beneficial flora, like lactic acid bacteria.23 While our ancestors likely didn‟t know this, th ey still used fermented foods regularly, likely due to the anecdotal results they witnessed.24 Indigenous people have patterns of illness very different from Western civilization; yet, they rapidly develop diseases, once exposed to Western foods and lifestyles.25,26Sandoval, Darleen A., and Randy J. Seeley. “The Microbes Made Me Eat It.” The Microbes Made Me Eat It. N.p., n.d. Web. 19 Dec.2014.Beneficial microbes in fermented foods can decrease anxiety, diminish perceptions of stress, and improve mental outlook.27 Brain derived neurotrophic factor (BDNF) can be increased via either probiotics, or fermented foods.28 BDNF is found in regions of the brain that control eating, drinking, and body weight; it likely contributes to the management of these functions.29 Stress is also known to alter gastrointestinal microflora.30 Probiotics and fermented foods can help to lower systemic inflammatory cytokines, decrease oxidative stress, improve nutritional status, and correct SIBO.31In one study, researchers even linked gut microbes to autism.32 In their study, a probiotic was found to help. This brings us to the possible exciting conclusion that probiotics and large servings of fermented foods may provide therapeutic strategies for neurodevelopmental disorders.33Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior inmice. Gastroenterology. 2011;141(2):599-609, 609.e1-3.Interestingly, researchers have also found that propionic acid, which is a short-chain fatty acid produced by microbiota, can have negative effects on health and behavior. A number of inherited and acquired conditions, such as propionic/methylmalonic acidemia, biotinidase/holocarboxylase deficiency, ethanol/valproate exposure, and mitochondrial disorders, are all known to result from elevations of propionic acid and other short-chain fatty acids.34The Western diet traditionally produces an unfavorable ratio of …good vs. bad‟ gut flora.35In addition, gut flora can help regulate fat storage.36 So not only are you more likely to have neurological problems, with a poor ratio of gut flora, but you are more likely to become obese.37 Hopefully all this information has driven home the fact that the Paleo Diet, which is anti-inflammatory, and rich in fermented foods, will deliver a positive ratio of healthy gut bacteria. It may seem like a small change, but it can make all the difference in the world, when it comes to your health.Bäckhed, Fredrik et al. “The Gut Microbiota as an Environmental Factor That Regulates Fat Storage.” Proceedings of the Nation al Academy of Sciences of the United States of America 101.44 (2004): 15718–15723. PMC. Web. 19 Dec. 2014.Casey ThalerREFERENCES[1] Steinkraus KH: Comparison of fermented foods of the East and West. In Fish Fermentation Technology. Edited by Lee CH, Steinkraus KH, Reilly PJ. Tokyo: United Nations University Press; 1993:1-12.[2] Steinkraus, K.H. (2002), Fermentations in World Food Processing. Comprehensive Reviews in Food Science and Food Safety, 1: 23–32.[3] Park KY, Jeong JK, Lee YE, Daily JW. Health benefits of kimchi (Korean fermented vegetables) as a probiotic food. J Med Food. 2014;17(1):6-20.[4] Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. J Affect Disord. 2012;140(3):205-14.[5] Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260-70.[6] Spalding A, Kernan J, Lockette W. The metabolic syndrome: a modern plague spread by modern technology. J Clin Hypertens (Greenwich). 2009;11(12):755-60.[7] Edwardson CL, Gorely T, Davies MJ, et al. Association of sedentary behaviour with metabolic syndrome: a meta-analysis. PLoS ONE. 2012;7(4):e34916.[8] Swain MR, Anandharaj M, Ray RC, Parveen rani R. Fermented fruits and vegetables of Asia: a potential source of probiotics. Biotechnol Res Int. 2014;2014:250424.[9] Rechenberg K, Humphries D. Nutritional interventions in depression and perinatal depression. Yale J Biol Med. 2013;86(2):127-37.[10] Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging.2006;10(5):377-85.[11] André C, Dinel AL, Ferreira G, Layé S, Castanon N. Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation. Brain Behav Immun. 2014;41:10-21.[12] Sánchez-villegas A, Toledo E, De irala J, Ruiz-canela M, Pla-vidal J, Martínez-gonzález MA. Fast-food and commercial baked goods consumption and the risk of depression. Public Health Nutr. 2012;15(3):424-32.[13] Agrawal R, Gomez-pinilla F. …Metabolic syndrome‟ in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J Physiol (Lond). 2012;590(Pt 10):2485-99.[14] Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev.2008;29(4):494-511.[15] Jacka FN, Mykletun A, Berk M, Bjelland I, Tell GS. The association between habitual diet quality and the common mental disorders in community-dwelling adults: the Hordaland Health study. Psychosom Med. 2011;73(6):483-90.[16] Borresen EC, Henderson AJ, Kumar A, Weir TL, Ryan EP. Fermented foods: patented approaches and formulations for nutritional supplementation and health promotion. Recent Pat Food Nutr Agric. 2012;4(2):134-40.[17] Conterno L, Fava F, Viola R, Tuohy KM. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease?. Genes Nutr. 2011;6(3):241-60.[18] Flint HJ. Obesity and the gut microbiota. J Clin Gastroenterol. 2011;45 Suppl:S128-32.[19] Parekh PJ, Arusi E, Vinik AI, Johnson DA. The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome. Front Endocrinol (Lausanne). 2014;5:47.[20] Sandoval DA, Seeley RJ. Medicine. The microbes made me eat it. Science. 2010;328(5975):179-80.[21] Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol. 2013;6(1):39-51.[22] Szaefer H, Licznerska B, Krajka-kuźniak V, Bartoszek A, Baer-dubowska W. Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines. Nutr Cancer. 2012;64(6):879-88.[23] Chelule PK, Mbongwa HP, Carries S, Gqaleni N. Lactic acid fermentation improves the quality of amahewu, a traditional South African maize-based porridge. Food Chem. 2010;122:656–661.[24] Anukam KC, Reid G. African traditional fermented foods and probiotics. J Med Food.2009;12(6):1177-84.[25] Lipski E. Traditional non-Western diets. Nutr Clin Pract. 2010;25(6):585-93.[26] Llaverias G, Danilo C, Wang Y, et al. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Am J Pathol. 2010;177(6):3180-91.[27] Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III – convergence toward clinical trials. Gut Pathog.2013;5(1):4.[28] Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141(2):599-609, 609.e1-3.[29] Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004;22(3):123-31.[30] Logan AC, Katzman M. Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses. 2005;64(3):533-8.[31] Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720-6.[32] Gilbert JA, Krajmalnik-brown R, Porazinska DL, Weiss SJ, Knight R. Toward effective probiotics for autism and other neurodevelopmental disorders. Cell. 2013;155(7):1446-8.[33] Parvez S, Malik KA, Ah kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006;100(6):1171-85.[34] Macfabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis. 2012;23[35] Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1(6):6ra14.[36] Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101(44):15718-23.[37] Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005;102(31):11070-5.。

血脑屏障上的P-糖蛋白与药物转运功能

血脑屏障上的P-糖蛋白与药物转运功能

・综 述・血脑屏障上的P -糖蛋白与药物转运功能左明新 刘晓东(南京210009中国药科大学药物代谢研究中心)摘要 目的:综述脑毛细血管内皮细胞上的P -糖蛋白药物外排功能。

方法:根据对有关的资料的分析、归纳、总结得出P -糖蛋白与脑内药物转运的关系。

结果:血脑屏障上的P -糖蛋白具有ATP 依赖性的药物外排泵的功能,能降低脑内药物的浓度。

结论:利用多药耐药性逆转剂有可能提高脑内的药物转运或者降低药物的通透性减少中枢神经系统的不良反应。

关键词 血脑屏障;P -糖蛋白;药物转运The P -glycoprotein at the blood -brain barrier and drugs deliveryZuo Mingxin (Zuo MX ),Liu Xiaodong (Liu XD )(Center of Drug Metabolism and Pharmacokinetics ,ChinaPharmacenutical University ,Nanjing 210009)ABSTRACT OBJECTIVE :Specific drug efflux from the endothelial cells of capillary blood vessels of brain mediated by p -glycoprotein (P -gp )is described.METHODS :The conclusion that the relationship between p -glycoptein and drug delivery was drawn from datum analysis induce and summary.RESU L TS :P -glycoprotein at the blood -brain was found to function as ATP -depended efflux pump transporting various drugs out of cells and decreasing the apparent permeability of brain.CO NCL USIO N :The utilization of multidrug resistance reverses may make it possible to inhance delivery of drugs into the brain or decrease the apparent permeability in order to prevent undesirable side effects in the central neural system.KEY WO R DS blood brain barrier ,P -glycoprotein ,drug delivery 血脑屏障在物质进入脑内的过程中起着重要作用,脑毛细血管内皮细胞在结构上与外周毛细血管内皮细胞不同,脑毛细血管内皮细胞连接紧密,缺乏孔道,因此,长期以来认为物质能否通过血脑屏障主要取决于物质分子的大小和物质的脂溶性,一般认为分子量小,脂溶性大的物质容易通过血脑屏障进入脑内。

67-演示文稿-药物代谢动力学

metabolized: “longer half-life”
Drug interaction of plasma protein binding
99.9% bound
+ Drug A: 1000 molecules Drug B w/ 94% bound 90.0% bound
1 molecules free
Intracellular
跨膜转运
• 被动转运
1 . 脂 溶 扩散 脂 / 水分配系数 扩散常数、膜面积、
浓度梯度;膜厚度
解离度( Ka pH pKa)
2. 水溶扩散 直径小于膜孔
3. 易化扩散 不耗能、需载体
• 主动转运 耗能、需载体 • 膜动转运 (胞饮、胞吐)耗能、不需载体
脂溶扩散
属被动转运 (passive transport)
Portal circulation
Intramuscular & subcutaneous injection
Passive diffusion + Filtration Rapid and complete absorption
Inhalation
Gaseous or volatile substances and aerosol can reach the absorptive site of th e lung.
消除 : 代谢 排泄 ( ME )
Therapeutic Goal is to:
Achieve drug concentrations… at the site of action (target tissue)… that are sufficiently high enough…
to produce the intended effect… without producing adverse drug reactions.

浅论不同神经功能评分标准在小鼠EAE模型评价中的比较

浅论不同神经功能评分标准在小鼠EAE模型评价中的比较【摘要】目的:比较不同的神经功能损伤评分标准对小鼠实验性自身免疫性脑脊髓炎运动功能障碍评估的效能。

方法:应用MOG35-55多肽加完全福氏佐剂乳化后免疫20只C57BL/6小鼠,复制EAE小鼠模型,并使用3种不同的评分标准观察和评估实验动物的发病情况,对实验小鼠在发病初期、高峰期的神经功能障碍进行定量的功能损伤评价。

结果:3种评分标准比较,在发病初期,15分法和7分法评估神经损伤症状的敏感性相当,比5分法高;高峰期,以症状评分与病理评分的相关性程度来比较3种评分法的效度,15分法效度最高,7分法次之。

结论:Weaver’s 15分法评价EAE模型神经功能损伤症状,具有明显的优势,推荐作为今后EAE研究的首选评分法。

【关键词】实验性自身免疫性脑脊髓炎动物模型评分标准Abstract: Objective: To compareseveral methods of clinical assessment standards in mice model of EAE. Methods: The mice models of experimental autoimmune encephalomyelitis (EAE) were established,and the neural symptoms and pathological changes were observed. Three clinical assessment methods,including 5-point,7-point and 15-point,were used to assess neurological function. Results: On the early onset,7-point,the 15-point disease score scales were more sensitivity than5-point score scale to the incidence of disease. And the 15-point disease score scale was strongly correlated with pathological changes on EAE model and had good validity. Conclusion: The15-point disease score scale has a obvious dominance for the assessment of the sympton of the neurological function. Therefore,the 15-point disease score scale is recommended as the first methodto select.Key words: experimental autoimmune encephalomyelitis ;animal model;mice ;clinical as-sessment实验性自身免疫性脑脊髓炎模型是国际公认的多发性硬化(multiple sclerosis,MS)动物模型,被广泛用于MS发病机制和评价免疫调节药物的实验研究。

D-阿洛糖对小鼠脑缺血再灌注血脑屏障影响

D-阿洛糖对小鼠脑缺血再灌注血脑屏障影响黄涛;高大宽;费舟;冯乐霄;殷安安;董秋峰;陈晓燕【期刊名称】《中华神经外科疾病研究杂志》【年(卷),期】2015(14)4【摘要】目的:研究D-阿洛糖对小鼠脑缺血再灌注损伤后血脑屏障的影响。

方法80只小鼠随机分为假手术组( sham组)、脑缺血模型组( MCAO组)、D-阿洛糖治疗组( D-allose组)、生理盐水对照组(NS组)。

采用插线法制备小鼠大脑中动脉栓塞(MCAO)模型,尾静脉注射D-阿洛糖(300 mg/kg),运用改良小鼠神经功能缺损评分( mNSS)对小鼠脑缺血再灌注损伤程度评分;通过1%氯化三苯基四氮唑( TTC)染色,计算脑梗面积百分比;运用干-湿重法,测脑含水率;通过伊文思蓝( EB)含量反映血脑屏障的损伤程度;通过HE染色观察脑缺血再灌注损伤后梗死区的病理变化;采用免疫组化检测基质金属蛋白酶9(MMP-9)的表达。

结果与MCAO组相比,D-allose可以明显降低小鼠脑缺血再灌注后神经功能缺损评分,减小小鼠脑梗死面积,减轻脑水肿,降低EB含量,减轻脑组织的病理损伤程度,并且明显减少MMP-9表达( P<0.05)。

结论D-阿洛糖可以保护小鼠脑缺血再灌注后的血脑屏障,其机制可能与抑制MMP-9的表达有关。

%Objective To study the effect of D-allose on on the blood-brain barrier permeability following focal cerebral ischemia/reperfusion in mice.Methods The focal cerebral ischemia-reperfusion model was induced by the middle cerebral artery occlusion(MCAO).80 male Balb/c mice were randomly divided into sham group, MCAO group, NS group, D-allose group.With a model of reversible middle cerebral artery occlusion in mice,D-allose was injected in caudal vein(300 mg/kg).The neurological deficit score was performed by modified neurological severity scores(mNSS), Infarct volume was calculated by triphenyl tetrazolium chloride (TTC) stain.Brain water content was measured by Dry/Wet method.Blood-brain barrier (BBB) permeability was evaluated by Evans blue extravasation. The histopathological changes was observed by HE staining and the expression of matrix metalloproteinase-9 (MMP-9) was detected by immunohistochemistry method.Results Compared with MCAO group, D-allose group significantly lowered neurological deficit score, reduced the infarct volume, alleviated brain water content markedly, D-allose diminished the extent and quantity of Evans blueextravasation(P<0.05).Compared with MCAO group, D-allose decreased the level of MMP-9 expression (P<0.05)and ameliorated the histopathological changes(P<0.05). Conclusion D-allose has the protective effect on the blood-brain barrier following focal cerebralischemia/reperfusion injury in mice, which is closely related to inhibition of MMP-9 expression.【总页数】5页(P297-301)【作者】黄涛;高大宽;费舟;冯乐霄;殷安安;董秋峰;陈晓燕【作者单位】第四军医大学西京医院神经外科,陕西西安710032;第四军医大学西京医院神经外科,陕西西安710032;第四军医大学西京医院神经外科,陕西西安710032;第四军医大学西京医院神经外科,陕西西安710032;第四军医大学西京医院神经外科,陕西西安710032;第四军医大学西京医院神经外科,陕西西安710032;第四军医大学西京医院神经外科,陕西西安710032【正文语种】中文【中图分类】R743【相关文献】1.通窍活血汤对脑缺血再灌注小鼠血脑屏障通透性及脑内单胺类神经递质含量的影响 [J], 刘亚芳;汪宁2.高压氧对脑缺血再灌注小鼠脑组织细胞粘附分子的表达及血脑屏障通透性的影响[J], 赵红;宋阳;奚卉;曹士信;陈学新3.高压氧对急性脑缺血再灌注小鼠AQP-4表达及血脑屏障通透性的影响 [J], 赵红;曹士信;卢晓梅;张海鹏;陈学新4.人参三七配伍对脑缺血再灌注损伤小鼠血脑屏障通透性及脑组织炎症反应的影响[J], 张楠;黄鑫;戴雨霖;越皓;于洋;刘淑莹5.芳香开窍药对脑缺血再灌注损伤小鼠血脑屏障通透性的影响 [J], 倪彩霞;曾南;汤奇;许福会;苟玲;王建;夏厚林因版权原因,仅展示原文概要,查看原文内容请购买。

基于“微生物-肠-脑轴”理论探讨从脾胃论治偏头痛

- 153 -①辽宁中医药大学 辽宁 沈阳 110847通信作者:成泽东基于“微生物-肠-脑轴”理论探讨从脾胃论治偏头痛梁爽① 成泽东① 【摘要】 偏头痛是临床上常见的慢性神经血管性疾病,以反复发作、顽固难愈为主要特点,给患者的身体和心理造成了重大困扰,极大地影响了患者的生活质量。

近年来对肠道微生态学说的研究不断深入,发现肠道菌群可通过多种途径参与偏头痛的发生发展。

本文基于“微生物-肠-脑轴”理论,从经络、气血、情志、痰浊4个方面进行探讨,为中医从脾胃论治偏头痛提供依据。

【关键词】 微生物-肠-脑轴 肠道菌群 脾胃 偏头痛 doi:10.14033/ki.cfmr.2024.05.037 文献标识码 A 文章编号 1674-6805(2024)05-0153-05 Based on "Microbial-gut-brain Axis" Theory to Explore the Treatment of Migraine from Spleen and Stomach/LIANG Shuang, CHENG Zedong. //Chinese and Foreign Medical Research, 2024, 22(5): 153-157 [Abstract] Migraine is a common chronic neurovascular disease in clinical practice, with repeated attacks, stubborn and difficult to heal as the main characteristics, to the patient's physical and psychological caused significant distress, greatly affecting the quality of life of patients. In recent years, the in-depth study of intestinal microecology theory has found that intestinal flora can participate in the occurrence and development of migraine through various ways. Based on the theory of "microbial-gut-brain axis", this paper discusses the four aspects of meridians, Qi and blood, emotions, phlegm turbidity, so as to provide the basis for the treatment of migraine by spleen and stomach in traditional Chinese medicine. [Key words] Microbial-gut-brain axis Intestinal flora Spleen and stomach Migraine First-author's address: Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China 偏头痛是临床上常见的神经血管性疾病,主要表现为偏侧中、重度搏动样反复发作的疼痛,一般持续4~72 h,可伴有恶心、呕吐、畏声、畏光或日常活动加重疼痛[1]。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

DOI: 10.1126/scitranslmed.3009759, 263ra158 (2014);6 Sci Transl Med et al.Viorica Braniste The gut microbiota influences blood-brain barrier permeability in miceEditor's Summarythe gut microbiota and the brain, initiated during the intrauterine period, is perpetuated throughout life.permeability, possibly through the regulation of tight junction proteins. These findings suggest that crosstalk between mice. However, fecal transplants from mice exposed to bacteria into adult germ-free mice reduced blood-brain barrier increased permeability of the blood-brain barrier. This elevated permeability was also observed in adult germ-free now show that germ-free pregnant dams, devoid of maternal microbes, have offspring that show et al.Braniste brain.of the brain. An intact blood-brain barrier is a crucial checkpoint for appropriate development and function of the The blood-brain barrier is an important gateway that controls the passage of molecules and nutrients in and out The Gut Microbiota and the Blood-Brain Barrier/content/6/263/263ra158.full.html can be found at:and other services, including high-resolution figures,A complete electronic version of this article /content/suppl/2014/11/17/6.263.263ra158.DC1.htmlcan be found in the online version of this article at: Supplementary Material/about/permissions.dtl in whole or in part can be found at:article permission to reproduce this of this article or about obtaining reprints Information about obtaining last week in December, by the American Association for the Advancement of Science, 1200 New York Avenue (print ISSN 1946-6234; online ISSN 1946-6242) is published weekly, except the Science Translational Medicine o n N o v e m b e r 20, 2014s t m .s c i e n c e m a g .o r g D o w n l o a d e d f r o mB L O O D-B R A I N B A R R I E RThe gut microbiota influences blood-brain barrier permeability in miceViorica Braniste,1*†Maha Al-Asmakh,1*Czeslawa Kowal,2*Farhana Anuar,1Afrouz Abbaspour,1 Miklós Tóth,3Agata Korecka,1Nadja Bakocevic,4Ng Lai Guan,4Parag Kundu,5Balázs Gulyás,3,5 Christer Halldin,3,5Kjell Hultenby,6Harriet Nilsson,7Hans Hebert,7Bruce T.Volpe,8Betty Diamond,2‡Sven Pettersson1,5,9†‡Pivotal to brain development and function is an intact blood-brain barrier(BBB),which acts as a gatekeeper to control the passage and exchange of molecules and nutrients between the circulatory system and the brain parenchyma.The BBB also ensures homeostasis of the central nervous system(CNS).We report that germ-free mice,beginning with intrauterine life,displayed increased BBB permeability compared to pathogen-free mice with a normal gut flora.The increased BBB permeability was maintained in germ-free mice after birth and during adulthood and was associated with reduced expression of the tight junction proteins occludin and claudin-5, which are known to regulate barrier function in endothelial tissues.Exposure of germ-free adult mice to a pathogen-free gut microbiota decreased BBB permeability and up-regulated the expression of tight junction proteins.Our results suggest that gut microbiota–BBB communication is initiated during gestation and propa-gated throughout life.INTRODUCTIONOur gut microbiota is important for many biological functions in the body,including intestinal development,barrier integrity and function(1,2),metabolism(3,4),the immune system(5),and the central ner-vous system(CNS).The effects of the gut microbiota on brain phys-iology include synaptogenesis,regulation of neurotransmitters andneurotrophic factors such as brain-derived neurotrophic factor and nerve growth factor-A1(6).However,the development of the CNS also includes the formation of an intact blood-brain barrier(BBB)thatensures an optimal microenvironment for neuronal growth and spec-ification(7).An intact and tightly regulated BBB is also required to protect against colonizing microbiota in neonates during the critical period of brain development(8,9).It also protects against exposure to “new”molecules and bacterial metabolites due to the postnatal metabolic switch from predominant dependence on carbohydrates during fetal life to a greater dependence on fatty acid catabolism after birth.The BBB begins to develop during the early period of intrauterine life(10,11)and is formed by capillary endothelial cells sealed by tight junctions,astrocytes,and pericytes.Tight junction proteins restricting paracellular diffusion of water-soluble substances from blood to the brain(12)consist mainly of transmembrane proteins such as claudins,tricellulin,and occludin,which are connected to the actin cytoskeleton by the zona occludens(ZO-1)(13).Tight junction proteins are dynamic structures and are subject to changes in expression,subcellular location, posttranslational modification,and protein-protein interactions under both physiological and pathophysiological conditions(12).Disruption of tight junctions due to disease or drugs can lead to impaired BBB function,compromising the CNS.Therefore,understanding how BBB tight junction proteins are affected by various factors is important for elucidating how to prevent and treat neurological diseases.Here,we report that the intestinal microbiota affects BBB permeability in both the fetal and adult mouse ing as a model system germ-free mice that have never encountered a live bacterium and pathogen-free mice that were reared in an environment free of monitored mouse patho-gens,we demonstrated that lack of gut microbiota is associated with increased BBB permeability and altered expression of tight junction pro-teins.Fecal transfer from mice with pathogen-free gut flora into germ-free mice or treatment of germ-free mice with bacteria that produce short chain fatty acids(SCFA)decreased the permeability of the BBB. RESULTSThe maternal gut microbiota can influence prenatal development of the BBBFirst,we characterized BBB permeability of mouse embryos with pathogen-free mothers by administering infrared-labeled immunoglobulin G2b(IgG2b)antibody to dams during timed pregnancies to see wheth-er the antibody was excluded by the BBB or was able to cross the BBB into the brain parenchyma.The qualitative analysis of mouse embryos with pathogen-free mothers showed a shift from a diffuse infrared-labeled antibody signal present within the embryonic brain at E13.5and E14.5 to a signal confined to the developing vasculature starting at E15.5to E17.5(Fig.1A).This signal was most pronounced in adult offspring of pathogen-free dams(Fig.1A).The quantitative analysis of the pene-tration into the fetal brain of infrared-labeled IgG2b antibody injected1Department of Microbiology,Tumor and Cell Biology,Karolinska Institute,17177Stockholm, Sweden.2Center for Autoimmune and Musculoskeletal Disease,The Feinstein Institute for Medical Research,North Shore-LIJ Health System,Manhasset,NY11030,USA.3Psychiatry Section,Department of Clinical Neuroscience,Karolinska Institutet,17176Stockholm, Sweden.4Singapore Immunology Network,Agency for Science,Technology and Research, Singapore138648,Singapore.5Lee Kong Chian School of Medicine,Nanyang Technolog-ical University,60Nanyang Drive,Singapore637551,Singapore.6Department of Laboratory Medicine,Karolinska Institutet,14186Stockholm,Sweden.7Department of Biosciences and Nutrition,Karolinska Institutet,and School of Technology and Health,KTH Royal In-stitute of Technology,Novum,SE-14157Huddinge,Sweden.8Laboratory of Functional Neuroanatomy,The Feinstein Institute for Medical Research,North Shore-LIJ Health System, Manhasset,NY11030,USA.9Singapore Centre on Environmental Life Sciences Engineering (SCELSE),Nanyang Technological University,Singapore637551,Singapore.*Co-first authors.†Corresponding author.E-mail:viorica.braniste@ki.se(V.B.);sven.pettersson@ki.se(S.P.)‡Co-senior authors.o n N o v e m b e r 2 0 , 2 0 1 4 s t m . s c i e n c e m a g . o r g D o w n l o a d e d f r o mintravenously into pathogen-free dams supported the qualitative data,showing a decrease at E15.5to E17.5(Fig.1B).In contrast,the analysis of E16.5brains from fetal mice of germ-free dams showed a diffuse sig-nal from the infrared-labeled IgG2b antibody (Fig.1C)present in the brain parenchyma (Fig.1,D and E).Higher-magnification images of the brain showed that the IgG2b antibody was limited only to the vessels in E16.5fetal mice of pathogen-free dams in contrast to age-matched fetal mice of germ-free dams (Fig.1,D and E).Because BBB integrity is controlled in part by sealing of the endothelial cells via tight junctions,we determined expression of the main tight junction proteins in brain ly-sates from E18.5fetal mice of pathogen-free versus germ-free dams.Expression of the brain endothelial tight junction proteins claudin-5and ZO-1was similar between the two groups,whereas the expression of occludin was significantly lower in the brain lysates from E18.5fetal mice of germ-free dams compared to that in age-matched fetal mice of pathogen-free dams (P <0.05)(Fig.1,F and G).Lack of gut microbiota isassociated with increased BBB permeability in adult miceThree techniques were used to determine whether the BBB was more permeable in germ-free adult mice:(i)in vivo positron emission tomography (PET)imaging with [11C]raclopride (Fig.2,A to C);(ii)extra-vasation of Evans blue tracer from the circulation (Fig.2D);and (iii)the capacity of an anti –N -methyl-D -aspartate receptor reactive antibody (R4A)to induce neuro-nal death after intravenous administration (Fig.2,E and F).In germ-free adult mice,[11C]raclopride uptake was increased compared with that for pathogen-free adult mice (Fig.2A),butonly during the first 4min after injection (Fig.2,B and C).This period of time rep-resents the “flow phase ”(that is,the pres-ence of the radioligand in the whole brain due to BBB permeability).Because the ra-dioligand was given in tracer doses,it does not exert any pharmacological effects on the brain (or body)vasculature or heart rate.These differences were present only in the initial flow phase and not in the later phase of the time activity curves,indicating no differences in radioligand binding to dopamine D 2receptors between the groups.Fluorescence microscopy images of dif-ferent brain regions (cortex,striatum,and hippocampus)of pathogen-free adult miceshowed the presence of Evans blue dye (bright red)only in the blood vessels,whereas Evans blue staining in germ-free mice was detected not only in the blood vessels but also in the brain parenchyma,demonstrating leakage of the dye across the BBB (Fig.2D).A group of mice receiving anintravenousFig.1.BBB integrity in fetal mice with germ-or pathogen-free mothers.(A )Representative lateral images of the brains of E13.5to E17.5mouse embryos and adult mice (ventral)1hour after infrared-labeled antibody was injected into pregnant pathogen-free (PF)mothers.Scale bar,1mm.(B )Quantitative analysis of antibody penetration into the fetal brain of mice with pathogen-free mothers.Data are ex-pressed as means ±SEM (7to 12embryos per group).***P <0.0001between E17.5group versus therest of the groups by one-way analysis of variance (ANOVA).(C )Representative images from the infrared-labeled antibody assay in E16.5mouse embryos with germ-free (GF)mothers.Scale bar,1mm.(D )Sagittalbrain sections from each of three E16.5mouse embryos with germ-or pathogen-free mothers after injecting the dam with IgG.IgG (top row of each pair,Alexa 594),CD31[platelet endothelial cell adhesion molecule (PECAM);bottom row of each pair,Alexa 488].Scale bar,500m m.(E )Maternal IgG in comparable regions of the brain of E16.5mouse embryos.Left column:IgG (Alexa 594).Middle column:CD31(PECAM;Alexa 488).Right column:Merged images.Scale bar,20m m.(F and G )Western blots of brain lysates from E18.5mouse fetuses with germ-or pathogen-free mothers probed for ZO-1,occludin,claudin-5,and glyceraldehyde phosphate dehydrogenase (GAPDH)(control).(F)Representative blots and (G)quantification.Black bars,PF.White bars,GF.Data were normalized for GAPDH expression and expressed as fold change,control fold (c.f.)PF.Data are means ±SEM (four to six mice per group).*P <0.05by Student ’s t test.ns,not significant.o n N o v e m b e r 20, 2014s t m .s c i e n c e m a g .o r g D o w n l o a d e d f r o minjection of tumor necrosis factor –a (TNF a )15hours before the ex-periment served as a positive control for BBB leakiness (Fig.2D).In germ-free adult mice,intravenous administration of the mono-clonal antibody R4A (250m g)was associated with abnormal neurons,marked by condensed cytoplasm and shrunken cell bodies in the CA1region of the hippocampus (Fig.2E,right panel).Abnormal neurons were not present or were rare in the CA1region of the hippocampus in the control group [phosphate-buffered saline (PBS)–treated germ-free group;Fig.2E,left panel].Furthermore,the R4A injection (at low and high doses)in germ-free adult mice was associated with a signif-icant reduction in neuron numbers in the CA1region of the hippo-campus,–38%for low-dose R4A (100m g)and –42%for high-dose (250m g)R4A compared with the PBS-treated germ-free control group (P <0.01)(Fig.2F).Intravenous administration of R4A in pathogen-free adult mice did not induce any changes,indicating that the R4A monoclonal antibody did not penetrate the BBB (Fig.2F).Fig.2.Increased BBB permeability in adult germ-free versus pathogen-free mice.(A )In vivo PET imaging of [11C]raclopride.Average coronal,sag-ittal,and horizontal PET summation images (brain area encircled in purple ellipse)in pathogen-free (PF)or germ-free (GF)adult mice 2to 3min after [11C]raclopride injection.(B )Average whole-brain time-activity curves of [11C]raclopride uptake expressed as %standardized uptake value (%SUV)in the two groups.*P <0.05and **P <0.05by one-way ANOVA.(C )Values (%SUV)obtained at 1-min intervals during the first 5min.Data are expressed as means ±SEM (five to six mice per group).(D )Representative images showing Evans blue dye extravasation (red)in three brain regions (cortex -upper row,striatum -middle row,and hippocampus -lower row)of germ-and pathogen-free mice and pathogen-free mice treated with TNF a (n =3mice per group).Blue,4′,6-diamidino-2-phenylindole (DAPI)(nuclear staining).Scale bar,50m m.(E and F )Neuronal loss in the hippocampus of germ-free adult mice receiving R4A antibody.(E)Photomicrographs of the CA1region of the hippocampus (middorsal,matched sections)from PBS-treated germ-free adult mice (left)and germ-free mice treated with different concentrations of R4A antibody (100and 250m g)(right).Yellow arrows in the right panel indicate neuronal loss and dying neurons in R4A-treated germ-free mice.Scale bar,10m m.(F)Quantitative analysis.Percent neuronal survival in the PBS-treated germ-free mouse group was set at 100%.**P <0.01by one-way ANOVA com-pared with the PBS-treated germ-free mouse group (n =3mice per group).o n N o v e m b e r 20, 2014s t m .s c i e n c e m a g .o r g D o w n l o a d e d f r o mVascular density and pericyte coverage show no difference in germ-and pathogen-free adult miceWe used intravital two-photon microscopy to exclude the possibility that high BBB permeability in germ-free adult mice was caused by higher vascular density in the ing the second harmonic gen-eration signals from collagen fibers of dura mater as a reference point, we observed that the subdural region,which is20to80m m below the dura mater,contains mainly large vessels(average diameter,~40m m) (Fig.3,A and C).In contrast,deeper regions of the brain120to180m m below the dura mater consist mostly of capillaries(Fig.3,B and D). Quantitative analysis of vasculature density in the brain revealed no sig-nificant gross differences between germ-and pathogen-free adult mice (Fig.3,C and D).Pericytes play an important role in regulating BBB properties,and decreased pericyte coverage has been associated with increased BBB permeability(10,14).Immunofluorescence staining using CD13,a cell surface marker for pericytes in different brain regions,revealed no difference in pericyte coverage between germ-and pathogen-free mice (Fig.3E).Brain endothelial tight junctions are altered in the absence of a gut microbiotaPermeability of CNS vessels is controlled in part by dynamic opening and closing of the endothelial junctions(15).Therefore,we assessed the expression of the main tight junction proteins(ZO-1,occludin,and claudin-5)by Western blot in three regions of an adult mouse brain:frontal cortex,striatum,and hippocampus.Significantly lowerexpression of occludin and claudin-5was observed in male germ-freemice compared with male pathogen-free mice in all three brain re-gions of interest(occludin:P<0.001in frontal cortex and hippocam-pus and P<0.05in striatum;claudin-5:P>0.001in frontal cortex andP<0.01in striatum and hippocampus)(Fig.4,A to F).In contrast,no difference in the expression of the cytoplasmic protein ZO-1was ob-served between the two groups(Fig.4,A to F).Similar patterns oftight junction protein expression were observed in the brains of femalegerm-free mice compared with female pathogen-free mice(fig.S1), suggesting that the effect of gut microbiota on the integrity of the BBB is independent of sex.In addition,immunofluorescence analysis confirmed lower expression of occludin and claudin-5in the brain vessels of adult male germ-free mice compared with that of adult male pathogen-free mice(Fig.4,G and H).The ultrastructure of the tight junctions was investigated by trans-mission electron microscopy analysis.In germ-free adult mice,the tight junctions appeared as a diffuse,disorganized structure compared with those in the pathogen-free group(Fig.4I).A scoring system was used to quantitatively determine the number of intact tight junctions as follows:perfect tight junctions,3;patches of blurriness,2;totally blurred,1(fig.S2shows examples of the rating scale).In the striatumof germ-free adult mice,the number of in-tact tight junctions was significantly lowerthan that in pathogen-free mice(P<0.001)(Fig.4J).BBB permeability and tightjunction protein expression areassociated with changes inthe gut microbiotaColonization of germ-free adult mice withflora from pathogen-free mice[conventio-nalized(CONV)]was associated with in-creased integrity of the BBB as shown byrestriction of the Evans blue tracer to theblood vessels and decreased extravasationof the dye into the brain parenchyma(Fig.5A).Quantitative analysis of tightjunction proteins in the CONV group com-pared with germ-free mice showed a signif-icant increase in the expression of occludinin the frontal cortex(P<0.05)and stria-tum(P=0.05)and of claudin-5in the hip-pocampus and striatum(P<0.05)(Fig.5,B to G).Increased expression of the in-tracellular protein ZO-1was detected inthe striatum and hippocampus of CONVmice compared with germ-free controls(P<0.05)(Fig.5,B to G).SCFAs or metabolites produced bybacteria affect BBB permeabilitySCFAs are known to enhance the integrityof the intestinal epithelial barrier(16,17)by facilitating the assembly of tight junctionsFig.3.Brain blood vessel and pericyte coverage in germ-and pathogen-free adult mice.(A to D)Two-photon imag-ing of brain blood vessels in germ-free(GF)and pathogen-free(PF)adult mice.Tetramethyl rhodamine isothiocyanate(TRITC)–dextran was applied retro-orbitally to highlight the brain blood vessels.(A)Representative images of brain vasculature20to80m m below the dura mater in germ-free(left panel)and pathogen-free(right panel)mice reveal mainly large vessels(average diameter,~40m m).(B)Representative images of the brain vasculature120to180m m below the dura mater in germ-free(left panel)and pathogen-free(right panel)mice showing mainly capillaries.(C)Quantitative analysis of blood vessel density20to80m m below the dura mater.(D)Quantitative analysis of blood vessel density120to 180m m below the dura mater.Scale bars,100m m.Data are representative of n=3independent experiments.(E)Representative images of pericyte coverage(CD13,green)in the cerebral cortex of pathogen-and germ-free mice(n=4mice per group).Laminin(red)was used as an endothelial cell marker.Scale bars,50m m.o n N o v e m b e r 2 0 , 2 0 1 4 s t m . s c i e n c e m a g . o r g D o w n l o a d e d f r o m(18).Hence,we evaluated BBB permeability in germ-free adult mice monocolonized with a single bacterial strain,Clostridium tyrobutyricum (CBut),that produces mainly butyrate(19,20)or with Bacteroides thetaiotaomicron(BTeta),which produces mainly acetate and propionate (21,22).We also evaluated germ-free adult mice given sodium butyrate by oral gavage for3days.Evans blue perfusion in CBut-,BTeta-,and sodium butyrate–treated mice demonstrated decreased BBB per-meability,compared to that in germ-free adult mice,that was equivalent to that of pathogen-free adult mice(Fig.6A).Administration of sodium butyrate to germ-free mice was associated with increased expression ofFig.4.Disrupted BBBtight junctions in thebrains of germ-andpathogen-free adultmice.(A to C)Rep-resentative Western blotsshowing the expressionof ZO-1,occludin,andclaudin-5in the(A)fron-tal cortex,(B)striatum,and(C)hippocampusof germ-free(GF)andpathogen-free(PF)adultmice.(D to F)Densito-metric analysis of West-ern blots from proteinsamples of the(D)fron-tal cortex,(E)striatum,and(F)hippocampus ofgerm-free mice(whitebars)compared withpathogen-free mice(blackbars).Data were nor-malized for GAPDH ex-pression and expressed as fold change, control fold(c.f.)PF.Values represent means±SEM(6to10mice per group).*P<0.05,**P<0.01,and***P<0.001 by Student’s t test compared with the corresponding pathogen-free mouse control.(G and H)Representative im-ages of germ-and pathogen-free mouse cerebral motor cortex stained for endo-thelial cells with(G and H)anti-laminin, (G)anti-occludin,and(H)anti–claudin-5antibodies.Scale bars,20m m.(I) Electron micrographs showing the dis-organized tight junction structure be-tween two endothelial cells in striatum (right panel,white arrows)of germ-free adult mice compared with striatum of pathogen-free mice(left panel).(J) Quantitative data indicate a decreased number of organized tight junctions in the striatum of germ-free mice com-pared with pathogen-free mice.Values represent means±SEM(seven mice per group).***P<0.001by Student’s t test.o n N o v e m b e r 2 0 , 2 0 1 4 s t m . s c i e n c e m a g . o r g D o w n l o a d e d f r o moccludin in the frontal cortex and hippocampus but had no effect on the expression of claudin-5(Fig.6,B to D).Furthermore,admin-istration of sodium butyrate or monocolonization of germ-free mice with C.tyrobutyricum was associated with an increase in histone acetylation in brain lysates (fig.S3).DISCUSSIONThe BBB is a physiological barrier that controls the passage of mole-cules between the brain parenchyma and the blood and in so doing allows proper functioning of neurons.Our results highlight the gut mi-crobiota as a potential regulator of BBB integrity.Here,we show that the lack of a normal gut microbiota in germ-free mice is associated with increased permeability of the BBB.This result was confirmed using three different techniques:in vivo PET imaging using radio-labeled ligand,vascular leakage of Evans blue dye,and neuronal damage after intravenous administration of R4A antibody.Furthermore,our data show that a more permeable BBB is observed in the fetal mice with germ-free mothers at E16.5to E18.5days of embryonic development compared to the fetal mice with pathogen-free mothers at the same stages of devel-opment.The increased permeability of the BBB in germ-free adult mice may partly be the consequence of disorganized tight junctions,as shown by electron microsco-py analysis,and low expression of the transmembrane tight junction proteins occludin and claudin-5.The “conventionali-zation ”of germ-free adult mice through transplant of the fecal microbiota from pathogen-free adult mice or by adminis-tering bacterial strains that produce SCFAs reinforced the integrity of the mouse BBB.The BBB matures progressively dur-ing intrauterine life and continues to ma-ture during the early postnatal stages of life (23).Our data confirm previous obser-vations (10,24)and show that closure of the BBB to IgG in pathogen-free mice occurs during the later stages of intra-uterine life.A recent study of Mfsd2a knock-out mice (lacking the transporter for the essential omega-3fatty acid docosahexaenoic acid)showed that the BBB in mice be-comes functional at E15.5,demonstrating complex regional and temporal differences in maturation (11).This coincides withour observation of the permeability of the embryonic BBB to maternal antibodies.In mice,gestational stage E15.5is a turn-ing point for the restriction of maternal antibody penetration into the fetal brain.Maternal antibodies or,more precisely,antibody delivered to the embryo through the placenta was our molecule of choicein our embryonic BBB studies as a physiological route of delivery.Re-duced closure of the BBB was observed in fetuses from germ-free dams.In humans,marked changes in the composition of the maternal gut microbiota have been observed between the first and the third tri-mesters of pregnancy (25).These observations,together with the present study,imply that the maternal gut microbiota might contribute to increased nutritional demands in late pregnancy,which would require more stringent control of BBB permeability in the growing offspring.The BBB is a complex structure formed by capillary endothelial cells,pericytes,and astrocytes (26).A difference in vascular density might be a confounding factor in assessing BBB permeability.In our study,increased invasion of circulating substances into the brain parenchyma appears not to be due to differences in large vascular structures between the two groups of mice as shown by a comparable equal visualization of the brain vasculature using 140kD TRITC-dextran.However,we cannot formally exclude that some microcapillary changes may still exist between the two groups.In germ-free adult mice,pericytecoverageFig.5.Microbial colonization of the gut changes BBB integrity.(A )Representative images from three mouse brain regions (frontal cortex,striatum,and hippocampus)showing Evans blue dye (red)in pathogen-free (PF)mice,germ-free (GF)mice,and germ-free mice colonized with pathogen-free flora for 14days (CONV).Blue,DAPI (nuclear staining).Scale bars,50m m.(B to G )Quantitative analysis of ZO-1,occludin,and claudin-5expression in the frontal cortex,striatum,and hippocampus of germ-free and CONV mice.Data were normal-ized for GAPDH expression and expressed as fold change,fold control (c.f.)GF.Values represent means ±SEM (four to six mice per group).*P <0.05by Student ’s t test compared to the germ-free control.o n N o v e m b e r 20, 2014s t m .s c i e n c e m a g .o r g D o w n l o a d e d f r o mFig.6.The effect of SCFAs on BBB permeability.(A)Extravasation of Evans blue dye(red)observed in the brain regions(frontal cortex,striatum,and hip-pocampus)of germ-free(GF)mice.In germ-free mice monocolonized with either C.tyrobutyricum(CBut)or B.thetaiotaomicron(BTeta)for2weeks or mice treated with the bacterial metabolite sodium butyrate(NaBu)for72hours,Evans blue dye was detected only in the blood vessels,without any leakage into the brain parenchyma.Blue,DAPI(nuclear staining).Scale bars,50m m.(B to D) Quantitative analysis of ZO-1,occludin,and claudin-5expression in brain lysates from germ-free mice gavaged with water(GF)or NaBu for72hours.Data were normalized for b-tubulin expression as a loading control and expressed as fold change,control fold(c.f.)GF.Values are expressed as means±SEM(four to five mice per group).*P<0.05by Student’s t test compared to the germ-free control.onNovember2,214stm.sciencemag.orgDownloadedfrom。

相关文档
最新文档